Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Slides:

Advertisements

Similar presentations

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.

Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Subgroup analyses for mortality after treatment with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). LAD, left anterior.

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

New tools in diagnosing renal artery stenosis

Treatment of acute renal failure

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Beta blockers in the management of chronic kidney disease

Follow-up of renal artery stenosis by duplex ultrasound

Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting Zoltán.

Volume 86, Issue 4, Pages (October 2014)

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Renal radiation-induced arterial stenosis

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Volume 80, Issue 8, Pages (October 2011)

Vikram S. Kashyap, MD, Ricardo N. Sepulveda, MD, James F

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies Ho Young Hwang, MD, Jin Hyun Kim, MD, Whal Lee,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 77, Issue 1, Pages 6-8 (January 2010)

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

Sequential Radial Artery Grafts for Multivessel Coronary Artery Bypass Graft Surgery: 10-Year Survival and Angiography Results Thomas A. Schwann, MD,

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

New tools in diagnosing renal artery stenosis

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Preprocedural neutrophil count predicts outcome in patients with advanced peripheral vascular disease undergoing percutaneous transluminal angioplasty

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease Robert.

Treatment of acute renal failure

Volume 63, Issue 1, Pages (January 2003)

Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.

Anemia as a risk factor for cardiovascular disease

Volume 59, Issue 4, Pages (April 2001)

Response to ‘Hepcidin levels in patients with renal disease’

Follow-up of renal artery stenosis by duplex ultrasound

Volume 62, Issue 1, Pages (July 2002)

Volume 61, Issue 1, Pages (January 2002)

Should kidney donors be genotyped for APOL1 risk alleles?

Outcomes of renal artery angioplasty and stenting using low-profile systems Brian W. Nolan, MD, Marc L. Schermerhorn, MD, Erin Rowell, MD, Richard J.

Nonelective cardiac surgery in the elderly: Is it justified?

Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients Bernard G. Jaar, Brad C. Astor, Jeffrey S.

Joseph F. Sabik, MD, Gabriel Olivares, MD, Sajjad Raza, MD, Bruce W

Volume 63, Issue 2, Pages (February 2003)

Volume 77, Issue 12, Pages (June 2010)

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

A personal experience with factors influencing survival after elective open repair of infrarenal aortic aneurysms Norman R. Hertzer, MD, Edward J. Mascha,

Coronary Revascularization on Balance: Robert L. Frye Lecture

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Long-term outcome of dialysis patients in the United States with coronary revascularization procedures Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.

Volume 64, Issue 4, Pages (October 2003)

Is complement a target for therapy in renal disease?

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease A.R. Chade, D. Brosh, S.T.

Volume 64, Issue 4, Pages (October 2003)

Davide Capodanno et al. JCIN 2009;2:

Volume 67, Issue 6, Pages (June 2005)

Prediction in idiopathic membranous nephropathy

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Impact of incidental renal artery stenosis on long-term mortality in patients with peripheral arterial disease undergoing vascular procedure Kwok-Wai.

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark Kidney International Volume 60, Issue 4, Pages 1490-1497 (October 2001) DOI: 10.1046/j.1523-1755.2001.00953.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan-Meier survival curve showing unadjusted survival according to the presence or absence of significant renal artery stenosis (RAS; P < 0.001). Symbols are: (thick line) <75% RAS; (thin line) ≥75% RAS. Kidney International 2001 60, 1490-1497DOI: (10.1046/j.1523-1755.2001.00953.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Adjusted survival according to the presence or absence of significant renal artery stenosis (RAS) in patients treated with percutaneous transluminal angioplasty (PTCA) (P < 0.001). Symbols are: (thick line) <75% RAS; (thin line) ≥75% RAS. Kidney International 2001 60, 1490-1497DOI: (10.1046/j.1523-1755.2001.00953.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Adjusted survival according to the presence or absence of significant renal artery stenosis (RAS) in patients treated with coronary artery bypass graft (CABG) (P < 0.001). Symbols are: (thick line) <75% RAS; (thin line) ≥75% RAS. Kidney International 2001 60, 1490-1497DOI: (10.1046/j.1523-1755.2001.00953.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Adjusted survival stratified for the severity of renal artery stenosis (RAS) (P < 0.001 for trend). Symbols are: (thick line) 10 to 75% RAS; (medium line) 75 to 95% RAS; (thin line) ≥95% RAS. Kidney International 2001 60, 1490-1497DOI: (10.1046/j.1523-1755.2001.00953.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Adjusted survival according to the presence of unilateral (thick line) or bilateral (thin line) renal artery stenosis (RAS) (P < 0.001). Kidney International 2001 60, 1490-1497DOI: (10.1046/j.1523-1755.2001.00953.x) Copyright © 2001 International Society of Nephrology Terms and Conditions